Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

Eur Respir Rev

Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Pneumologie, Centre de Référence National des Maladies Pulmonaires Rares, Lyon, France Université de Lyon, Université Lyon I, INRA, UMR754 INRA, Vetagrosup EPHE IFR 128, Lyon, France.

Published: September 2015

http://ow.ly/PYUCC

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487678PMC
http://dx.doi.org/10.1183/16000617.0051-2015DOI Listing

Publication Analysis

Top Keywords

rare pulmonary
4
pulmonary diseases
4
diseases orphan
4
orphan drugs
4
drugs stand
4
stand going
4
going to?
4
to? http//owly/pyucc
4
rare
1
diseases
1

Similar Publications

Empyema, a type of pleural effusion characterized by pus accumulation in the pleural space, is most often caused by bacterial infections, typically as a complication of pneumonia. This case report presents a 70-year-old man with chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, and chronic bilateral hydropneumothoraces, who developed pyopneumothorax due to dual infections with  and . The patient presented with worsening dyspnea, hypoxemia, and respiratory acidosis, requiring hospitalization and chest tube thoracostomy.

View Article and Find Full Text PDF

Systemic capillary leak syndrome (SCLS) is a rare and life-threatening disorder characterized by acute hypotension, hypoalbuminemia, and hemoconcentration, which often results in severe respiratory complications, such as pulmonary edema. SCLS can be triggered by infections, including COVID-19, and is associated with a high mortality rate. Here, we report a case of COVID-19-associated SCLS in a 68-year-old man.

View Article and Find Full Text PDF

Malignant hyperthermia is a pharmacogenetic disorder that manifests clinically as a hypermetabolic crisis when a patient with a mutation in the ryanodine or dihydropyridine receptor genes is exposed to neuromuscular blocking agents. Depolarizing neuromuscular agents are known to cause malignant hyperthermia, but cases caused by nondepolarizing agents are rarely reported. We present a case consistent with malignant hyperthermia after receipt of cisatracurium, a nondepolarizing anesthetic agent.

View Article and Find Full Text PDF

A 34-year-old man with sudden palpitations, dyspnea, and chest pain was found to have tachycardia and unilateral pulmonary congestion. Intravenous adenosine restored sinus rhythm. Imaging and pathology confirmed an atrial myxoma with severe mitral regurgitation, requiring surgical excision and mitral valve replacement.

View Article and Find Full Text PDF

This case report describes rare accurate historical documentation of progressive reduction in effort tolerance over time in a patient with untreated congenital heart disease and pulmonary hypertension.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!